TREATMENT OF KNEE OSTEOARTHRITIS WITH MESENCHYMAL STEM CELLS ARTHROSCOPY AND PHYSIOTHERAPY: EVALUATION WITH SF-36
Keywords:
Orthopedic, MSC, OA, SF-36, Quality of life, PhysiotherapyAbstract
Introduction: Osteoarthritis (OA), a chronic degenerative joint disease, significantly impacts quality of life (QoL) and poses economic burdens, especially as aging populations grow. While no therapy fully regenerates cartilage, mesenchymal stem cells (MSC) offer a promising treatment for the condition.
Aim: This study aimed to evaluate effects of arthroscopically administered MSC therapy in conjunction with an 8-week standard physiotherapy regimen for patients with knee OA.
Material and methods: This monocentric clinical study involved 35 patients with knee OA (aged 45-65 years, of both genders), who treated with arthroscopy and MSC. Health status was assessed pre- and post-treatment using the 36-Item Short Form Health Survey (SF-36). Additionally, the influence of age and gender on treatment efficacy was analyzed to understand demographic impacts on therapeutic response.
Results: The average SF-36 score after treatment among male patients demonstrated better condition compared to female patients across individual concepts or domains, and overall SF-36 score.
The best condition of 100% according to the SF-36 score after treatment was found among males for the role limitations due to physical health and role limitations due to emotional problems. Among females, these domains also represented best post-treatment condition, with half of them achieving SF-36 scores of 100%. Younger age was significantly associated with better outcomes across all SF-36 concepts.
Conclusion: The results of the study highlight the potential of MSC arthroscopy in combination with physiotherapy, in managing knee OA in this group of subjects. To better understand long-term effects and optimize treatment, larger-scale randomized controlled trials are necessary.
References
Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol 2014; 28(1): 5-15. doi: 10.1016/j.berh.2014.01.004.
Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. [published correction appears in Dtsch Arztebl Int 2010; 107(16): 294. Dtsch Arztebl Int 2010; 107(9): 152-162. doi: 10.3238/arztebl.2010.0152.
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 2019; 393(10182): 1745-1759. doi: 10.1016/S0140-6736(19)30417-9.
Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, et al. Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019. Arthritis & rheumatology (Hoboken, NJ) 2022; 74(7): 1172-1183. https://doi.org/10.1002/art.42089.
Garay-Mendoza D, Villarreal-Martínez L, Garza-Bedolla A, Perez-Garza DM, Acosta-Olivo C,Vilchez-Cavazos F, et al. The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis. Int J Rheum Dis 2018; 21(1): 140-147. doi: 10.1111/1756-185X.13139.
van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989; 48(4): 271-280. doi: 10.1136/ard.48.4.271.
Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, et al. Osteoarthritis. Lancet 2015; 386(9991): 376-387. doi: 10.1016/S0140-6736(14)60802-3.
Anandacoomarasamy A, Fransen M, March L. Obesity and the musculoskeletal system. Curr Opin Rheumatol 2009; 21(1): 71-77. doi: 10.1097/bor.0b013e32831bc0d7.
Hussain SM, Cicuttini FM, Alyousef B, Wang Y. Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review. Climacteric 2018; 21(2): 132-139. doi: 10.1080/13697137.2017.1421926.
Garstang SV, Stitik TP. Osteoarthritis: epidemiology, risk factors, and pathophysiology. Am J Phys Med Rehabil 2006; 85(11 Suppl): S2-S14. doi: 10.1097/01.phm.0000245568.69434.1a.
Fransen M, Bridgett L, March L, Hoy D, Penserga E, Brooks P. The epidemiology of osteoarthritis in Asia. Int J Rheum Dis 2011; 14(2): 113-121. doi: 10.1111/j.1756-185X.2011.01608.x
Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009; 374(9696): 1196-1208. doi: 10.1016/S0140-6736(09)61460-4.
Wortley D, An JY, Heshmati A. Tackling the Challenge of the Aging Society: Detecting and Preventing Cognitive and Physical Decline through Games and Consumer Technologies. Healthc Inform Res 2017; 23(2): 87-93. doi: 10.4258/hir.2017.23.2.87.
Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009; 15(8 Suppl): S230-S235. PMID: 19817509.
Hawker GA. Osteoarthritis is a serious disease. Clinical and experimental rheumatology 2019; 37 Suppl 120(5): 3-6. PMID: 31621562.
Felson D. T. Developments in the clinical understanding of osteoarthritis. Arthritis research & therapy 2009; 11(1): 203. doi: 10.1186/ar2531.
Mulrooney E, Neogi T, Dagfinrud H, Hammer HB, Pettersen PS, Gaarden TL, et al. The associations of psychological symptoms and cognitive patterns with pain and pain sensitization in people with hand osteoarthritis. Osteoarthr Cartil Open 2022; 4(2): 100267. doi: 10.1016/j.ocarto.2022.100267.
Pereira D, Severo M, Barros H, Branco J, Santos RA, Ramos E. The effect of depressive symptoms on the association between radiographic osteoarthritis and knee pain: a cross-sectional study. BMC musculoskeletal disorders 2013; 14: 214. doi: 10.1186/1471-2474-14-214.
Murphy JM, Dixon K, Beck S, Fabian D, Feldman A, Barry F. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum 2002; 46(3): 704-713. doi: 10.1002/art.10118.
Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 2017; 35(6): 1651-1652. doi: 10.1002/stem.2589]. Stem Cells 2014; 32(5): 1254-1266. doi:10.1002/stem.1634.
Abraham NS, El-Serag HB, Hartman C, Richardson P, Deswal A. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther 2007; 25(8): 913-924. doi: 10.1111/j.1365-2036.2007.03292.x.
Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008; 10(5): 223. doi: 10.1186/ar2514.
Xia P, Wang X, Lin Q, Li X. Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop 2015; 39(12): 2363-2372. doi: 10.1007/s00264-015-2785-8.
Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthritis Cartilage 2022; 30(1): 10-16. doi: 10.1016/j.joca.2021.05.007.
Shane Anderson A, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol 2010; 24(1): 15-26. doi: 10.1016/j.berh.2009.08.006.
Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: a review. Am J Transl Res 2021; 13(2): 448-461. PMID: 33594303.
Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013; 111(1): 52-58. doi: 10.1093/bja/aet127.
Espinosa-Salas S, Bagherzadeh L, Wafford QE, Witte G, Schnitzer TJ. Does sex affect the efficacy of systemic pharmacological treatments of pain in knee osteoarthritis? A systematic review. Osteoarthr Cartil Open 2024; 6(1): 100438. doi: 10.1016/j.ocarto. 2024.100438.
Ferre IM, Roof MA, Anoushiravani AA, Wasterlain AS, Lajam CM. Understanding the Observed Sex Discrepancy in the Prevalence of Osteoarthritis. JBJS Rev 2019; 7(9): e8. doi: 10.2106/JBJS.RVW.18.00182.
Emadedin M, Aghdami N, Taghiyar L, Fazeli R, Moghadasali R, Jahangir S, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 2012; 15(7): 422-428. PMID: 22724879.
Vega A, Martín-Ferrero MA, Del Canto F, Alberca M, Garcia V, Munar A, et al. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation 2015; 99(8): 1681-1690. doi: 10.1097/TP.0000000000000678.
Orozco L, Munar A, Soler R, Alberca M, Soler F, Huguet M, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 2013; 95(12): 1535-1541. doi: 10.1097/TP.0b013e318291a2da.
